相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Controlled Trial of Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscesses in Patients at Risk for Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
Gillian R. Schmitz et al.
ANNALS OF EMERGENCY MEDICINE (2010)
Randomized, Controlled Trial of Antibiotics in the Management of Community-Acquired Skin Abscesses in the Pediatric Patient
Myto Duong et al.
ANNALS OF EMERGENCY MEDICINE (2010)
Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
Molly E. Steed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the Seesaw Effect)
Soo-Jin Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System A Population-Based Study
Tony Antoniou et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Expanded Clinical Presentation of Community-Acquired Methicillin-Resistant Staphylococcus aureus Pneumonia
L. Jason Lobo et al.
CHEST (2010)
Update on Cardiovascular Implantable Electronic Device Infections and Their Management A Scientific Statement From the American Heart Association
Larry M. Baddour et al.
CIRCULATION (2010)
Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases
Becky A. Miller et al.
CLINICAL INFECTIOUS DISEASES (2010)
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S-aureus skin infections
E. S. Yang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
Young Ju Jung et al.
CRITICAL CARE MEDICINE (2010)
Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
Miguel Sanchez Garcia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin
Heather Nace et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Community-associated meticillin-resistant Staphylococcus aureus
Frank R. DeLeo et al.
LANCET (2010)
The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis A Prospective Investigation
Arthur Jeng et al.
MEDICINE (2010)
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
Lonneke G. M. Bode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CURRENT CONCEPTS Nosocomial Bacterial Meningitis
Diederik van de Beek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection
Pauline Yoong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
Avisheh Forouzesh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pilot Study of Ampicillin-Ceftriaxone Combination for Treatment of Orthopedic Infections Due to Enterococcus faecalis
G. Euba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis
G. Euba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
J. M. Miro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine US Medical Centers from 2002 to 2006
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pediatric Antibody Response to Community-Acquired Staphylococcus aureus Infection Is Directed to Panton-Valentine Leukocidin
Eric L. Brown et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Doxycycline, Not Minocycline, Induces Its Own Resistance in Multidrug-Resistant, Community-Associated Methicillin-Resistant Staphylococcus aureus Clone USA300
Brian S. Schwartz et al.
CLINICAL INFECTIOUS DISEASES (2009)
Prospective, Randomized Trial of 10 Days versus 30 Days of Antimicrobial Treatment, Including a Short-Term Course of Parenteral Therapy, for Childhood Septic Arthritis
Heikki Peltola et al.
CLINICAL INFECTIOUS DISEASES (2009)
Modeling the Invasion of Community-Acquired Methicillin-Resistant Staphylococcus aureus into Hospitals
Erica M. C. D'Agata et al.
CLINICAL INFECTIOUS DISEASES (2009)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Telavancin: A Novel Lipoglycopeptide
Louis D. Saravolatz et al.
CLINICAL INFECTIOUS DISEASES (2009)
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2009)
Salvage Treatment for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Efficacy of Linezolid With or Without Carbapenem
Hee-Chang Jang et al.
CLINICAL INFECTIOUS DISEASES (2009)
Infection Following Operative Treatment of Ankle Fractures
Charalampos G. Zalavras et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Topical Therapy for Methicillin-Resistant Staphylococcus aureus Colonization: Impact on Infection Risk
Ari Robicsek et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy
Fred C. Tenover et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
Steven N. Leonard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Safety and Efficacy of Daptomycin in the Treatment of Osteomyelitis: Results from the CORE® Registry
J. A. Crompton et al.
JOURNAL OF CHEMOTHERAPY (2009)
Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus
Jana M. Swenson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus
Reinout Naesens et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
A Comparison of Early Versus Late Conversion From Intravenous to Oral Therapy in the Treatment of Septic Arthritis
Robert Tracy Ballock et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2009)
USA300 is the Predominant Genotype Causing Staphylococcus aureus Septic Arthritis in Children
Maria A. Carrillo-Marquez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
TRIMETHOPRIM-SULFAMETHOXAZOLE OR CLINDAMYCIN FOR TREATMENT OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS
David Y. Hyun et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate
Adam Frymoyer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus
Daniel J. Elliott et al.
PEDIATRICS (2009)
Trends in US Hospital Admissions for Skin and Soft Tissue Infections
John Edelsberg et al.
EMERGING INFECTIOUS DISEASES (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus
Daniel J. Pallin et al.
ANNALS OF EMERGENCY MEDICINE (2008)
Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men
Binh An Diep et al.
ANNALS OF INTERNAL MEDICINE (2008)
Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
V. Prakash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Activities of Daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus aend its stable small-colony variant in human monocyte-derived macrophages and in broth
Aldona L. Baltch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus
David J. Riedel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections
Joshua Perlroth et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Pediatric mediastinitis as a complication of methicillin-resistant Staphylococcus aureus retropharyngeal abscess
Charles T. Wright et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2008)
Early Microbiological Response to Linezolid vs Vancomycin in Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Richard G. Wunderink et al.
CHEST (2008)
Colonization, fomites, and virulence: Rethinking the pathogenesis of community-associated methicillin-resistant staphylococcus aureus infection
Loren G. Miller et al.
CLINICAL INFECTIOUS DISEASES (2008)
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San francisco, 2004-2005
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin
Dong Heun Lee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection
Richard A. Proctor
CLINICAL INFECTIOUS DISEASES (2008)
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2008)
Management of methicillin-resistant Staphylococcus aureus bacteremia
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2008)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Septic arthritis: current diagnostic and therapeutic algorithm
Catherine J. Mathews et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Strategies to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus in Acute Care Hospitals
David P. Calfee et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals
Deverick J. Anderson et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
Susan J. Rehm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage
Juan-Ignacio Alos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase
Cesar A. Arias et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin
R. M. Gallagher et al.
JOURNAL OF INFECTION (2008)
Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
Daniel J. Livorsi et al.
JOURNAL OF INFECTION (2008)
Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections
Julia C. Dombrowski et al.
JOURNAL OF INFECTION (2008)
Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report
Goro Nagashima et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2008)
Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus
Randall G. Fisher et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections
Susan M. Abdel-Rahman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Influenza-associated pediatric mortality in the United States:: Increase of Staphylococcus aureus coinfection
Lyn Finelli et al.
PEDIATRICS (2008)
Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients
Qiang Wang et al.
SURGICAL NEUROLOGY (2008)
Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin an dantomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006
Robert L. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
Sung-Han Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital
Timothy C. Lee et al.
AMERICAN JOURNAL OF SURGERY (2007)
Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis
Kevin B. Laupland et al.
CRITICAL CARE MEDICINE (2007)
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
K. Georg Kreyrnann et al.
CRITICAL CARE MEDICINE (2007)
Daptomycin therapy for invasive Gram-positive bacterial infections in children
Monica I. Ardura et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infectionv
Priya M. Rajendran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy Neonates
Regine M. Fortunov et al.
PEDIATRICS (2007)
Experience with linezolid therapy in children with Osteoarticular infections
Chih-Jung Chen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis
Shafic Said Al-Nammari et al.
SPINE (2007)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series
Nalini Rao et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Clinical experience with daptomycin for the treatment of patients with osteomyelitis
Kenneth C. Lamp et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers:: A cluster randomized controlled trial
Michael W. Ellis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Persistent Staphylococcus aureus Bacteremia -: An analysis of risk factors and outcomes
Claudia Hawkins et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Limitations of vancomycin in the management of resistant staphylococcal infections
Marin H. Kollef
CLINICAL INFECTIOUS DISEASES (2007)
Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus:: A randomized, placebo-controlled, double-blind clinical trial
C. Wendt et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus
Joerg J. Ruhe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2007)
Experience With Daptomycin in Staphylococcus Bone and Joint Infections Case Series and Emergence of Nonsusceptibility
Linda Shipton et al.
INFECTIOUS DISEASES IN CLINICAL PRACTICE (2007)
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis:: an in vitro and in vivo simulation using historical and current dosing strategies
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid
A. T. Kessler et al.
INFECTION (2007)
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus
Mary Jo Cenizal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Point:: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F. Mohr et al.
CLINICAL INFECTIOUS DISEASES (2007)
Counterpoint:: Vancomycin and Staphylococcus aureus -: An antibiotic enters obsolescence
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2007)
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF
Satish K. Pillai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
Meghan N. Jeffres et al.
CLINICAL THERAPEUTICS (2007)
Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis
Naval G. Daver et al.
JOURNAL OF INFECTION (2007)
Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid
C. A. Aboltins et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Community- and health care-associated methicillin-resistant Staphylococcus aureus:: a comparison of molecular epidemiology and antimicrobial activities of various agents
Brian T. Tsuji et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center
Linda L. Han et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
The management and outcome of spinal implant infections: Contemporary retrospective cohort study
Todd J. Kowalski et al.
CLINICAL INFECTIOUS DISEASES (2007)
Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis
Jean Paul Remadi et al.
ANNALS OF THORACIC SURGERY (2007)
Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections:: Impact of antimicrobial therapy on outcome
Joerg J. Ruhe et al.
CLINICAL INFECTIOUS DISEASES (2007)
Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin
Benjamin C. Gebhart et al.
PHARMACOTHERAPY (2007)
Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations:: A systematic review of the evidence from comparative trials
Matthew E. Falagas et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
Meta-analysis: Intravenous immunoglobulin in critically ill adult patients with sepsis
Alexis F. Turgeon et al.
ANNALS OF INTERNAL MEDICINE (2007)
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides
Mandy Wootton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic
John D. Szumowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Linezolid for the treatment of patients with central nervous system infection
Fotinie Ntziora et al.
ANNALS OF PHARMACOTHERAPY (2007)
Linezolid therapy for infective endocarditis
P. Munoz et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization
Andrew E. Simor et al.
CLINICAL INFECTIOUS DISEASES (2007)
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus
Dennis L. Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains
Ronny Beer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid
Seok-Ming Toh et al.
MOLECULAR MICROBIOLOGY (2007)
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology
Kim Credito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005
Miriam Wiese-Posselt et al.
CLINICAL INFECTIOUS DISEASES (2007)
Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices
Laney Jorgenson et al.
PEDIATRIC NEUROSURGERY (2007)
Osteomyelitis
Irene G. Sia et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Keith A. Rodvold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients
Pavlos Myrianthefs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period
Guiqing Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Changing patterns of acute hematogenous osteomyelitis and septic arthritis - Emergence of community-associated methicillin-resistant Staphylococcus aureus
Sandra R. Arnold et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection
Pia S. Pannaraj et al.
CLINICAL INFECTIOUS DISEASES (2006)
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
Mark Benvenuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Venous thrombosis and thromboembolism in children with osteomyelitis
Shelley E. Crary et al.
JOURNAL OF PEDIATRICS (2006)
Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and β-lactam antibiotics
Paige M. Fox et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea
David Raveh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Methicillin-resistant S-aureus infections among patients in the emergency department
Gregory J. Moran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus
Tina Rutar et al.
OPHTHALMOLOGY (2006)
Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
L Friedman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
Jeffrey C. Hageman et al.
EMERGING INFECTIOUS DISEASES (2006)
Antibiotic use in pregnancy and lactation - What is and is not known about teratogenic and toxic risks
Gerard G. Nahum et al.
OBSTETRICS AND GYNECOLOGY (2006)
Venous thrombosis associated with staphylococcal osteomyelitis in children
BE Gonzalez et al.
PEDIATRICS (2006)
Methicillin-resistant Staphylococcus aureus in community-acquired meningitis
M. von Specht et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Adherence issues related to the selection of antistaphylococcal or antifungal antibiotic suspensions for children
RW Steele et al.
CLINICAL PEDIATRICS (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children
KG Hultén et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis
P Gerber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Conservative management of patients with cerebrospinal fluid shunt infections
EM Brown et al.
NEUROSURGERY (2006)
A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period
S Sacar et al.
BMC INFECTIOUS DISEASES (2006)
Successful treatment of staphylococcal toxic shock syndrome with linezolid: A case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2006)
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy
AF Shorr et al.
CRITICAL CARE MEDICINE (2006)
Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg
I Mohammedi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus Bacteremia
David Hirschwerk et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin
DJ Skiest
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll children's health plan
K Purcell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
FM Marty et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States
FC Tenover et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains
RN Jones
CLINICAL INFECTIOUS DISEASES (2006)
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
JB Patel et al.
CLINICAL INFECTIOUS DISEASES (2006)
Practice guidelines for the diagnosis and management of skin and soft-tissue infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam
J Breedt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?
JR Zahar et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin
HR Vikram et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections -: A 14-year study at Driscoll Children's Hospital
K Purcell et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2005)
Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus -: Importance of treatment with antimicrobials inhibiting exotoxin production
ST Micek et al.
CHEST (2005)
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus
MK Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Brief report:: Staphylococcus aureus sepsis and the waterhouse-friderichsen syndrome in children
PV Adem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult:: Clinical features and therapeutic outcomes
DH Priest et al.
SOUTHERN MEDICAL JOURNAL (2005)
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: Results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam
EJ Ellis-Grosse et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection
BE Gonzalez et al.
CLINICAL INFECTIOUS DISEASES (2005)
Staphylococcus aureus native valve infective endocarditis:: Report of 566 episodes from the International Collaboration on Endocarditis Merged Database
JM Miro et al.
CLINICAL INFECTIOUS DISEASES (2005)
The burden of Staphylococcus aureus infections on hospitals in the United States -: An analysis of the 2000 and 2001 nationwide inpatient sample database
GA Noskin et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
BT Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
ABSCESS: Applied bedside sonography for convenient evaluation of superficial soft tissue infections
BT Squire et al.
ACADEMIC EMERGENCY MEDICINE (2005)
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
PF Smith et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Staphylococcus aureus endocarditis -: A consequence of medical progress
VG Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Three-year surveillance of community-acquired Staphylococcus aureus infections in children
SL Kaplan et al.
CLINICAL INFECTIOUS DISEASES (2005)
Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association
LM Baddour et al.
CIRCULATION (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas
S Chavez-Bueno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections:: Case series and review of the literature
JJ Ruhe et al.
CLINICAL INFECTIOUS DISEASES (2005)
Linezolid and rifampin:: Drug interaction contrary to expectations?
H Egle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Methicillin-resistant staphylococcus aureus disease in three communities
SK Fridkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles
LG Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Purpura fulminans due to Staphylococcus aureus
GR Kravitz et al.
CLINICAL INFECTIOUS DISEASES (2005)
Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA):: successful treatment with linezolid in combination with intraventricular vancomycin
F Amod et al.
JOURNAL OF INFECTION (2005)
A clone of methicillin-resistant Staphylococcus aureus among professional football players
SV Kazakova et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant
G Vartzelis et al.
INFECTION (2005)
Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections
BA Lipsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Inducible clindamycin resistance in staphylococci: Should clinicians and microbiologists be concerned?
JS Lewis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes
JS Francis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis
KW Broder et al.
ANNALS OF PLASTIC SURGERY (2004)
Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients
HFL Wertheim et al.
ANNALS OF INTERNAL MEDICINE (2004)
Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens:: Implications for therapy of toxic shock syndrome
J Darenberg et al.
CLINICAL INFECTIOUS DISEASES (2004)
Staphylococcus aureus bacteremia and endocarditis:: The Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia
J Abraham et al.
AMERICAN HEART JOURNAL (2004)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression
K Bernardo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Linezolid in the treatment of osteomyelitis: Results of compassionate use experience
CR Rayner et al.
INFECTION (2004)
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus
MC Lee et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections
M Adra et al.
ANNALS OF PHARMACOTHERAPY (2004)
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis
P Cottagnoud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia
A Combes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients
DM Young et al.
ARCHIVES OF SURGERY (2004)
Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis
MJ Hepburn et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Peripheral neuropathy associated with prolonged use of linezolid
AM Bressler et al.
LANCET INFECTIOUS DISEASES (2004)
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children
G Martínez-Aguilar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Polyclonal immunoglobulin for treatment of bacterial sepsis: A systematic review
J Pildal et al.
CLINICAL INFECTIOUS DISEASES (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Panton-Valentine leukocidin and staphyloccoccal skin infections in schoolchildren
K Boubaker et al.
EMERGING INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Current concepts: Prosthetic-joint infections
W Zimmerli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antibiotic treatment of Gram-positive bone and joint infections
ESR Darley et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis - A propensity analysis
HR Vikram et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection
TS Naimi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
R Cha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center
B Bozdogan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin:: An evidence-based review
KB Laupland et al.
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid for the treatment of complicated skin and skin structure infections in children
R Yogev et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Safety and tolerability of linezolid in children
L Saiman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates
JG Deville et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus
FY Chiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study
FY Chang et al.
MEDICINE (2003)
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy
AD Tice et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children
JF Marcinak et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2003)
Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy
B Pfausler et al.
JOURNAL OF NEUROSURGERY (2003)
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis
MR Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods
C Jacqueline et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
RG Wunderink et al.
CLINICAL THERAPEUTICS (2003)
Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil
REC d'Oliveira et al.
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE (2003)
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid: The first oxazolidinone antimicrobial
RC Moellering
ANNALS OF INTERNAL MEDICINE (2003)
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus
P Grohs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid
RA Howe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era
HR Reynolds et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2003)
Linezolid resistance in Staphylococcus aureus:: Characterization and stability of resistant phenotype
SK Pillai et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA)
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients
AM Loeffler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci
A Sander et al.
INTENSIVE CARE MEDICINE (2002)
Treatment of cerebrospinal fluid shunt infections: a decision analysis
RT Schreffler et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
AL Frank et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Intrapulmonary pharmacokinetics of linezolid
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Long-term outcome of infective endocarditis: The impact of early surgical intervention
J Bishara et al.
CLINICAL INFECTIOUS DISEASES (2001)
The treatment of cerebrospinal fluid shunt infections - Results from a practice survey of the American Society of Pediatric Neurosurgeons
WE Whitehead et al.
PEDIATRIC NEUROSURGERY (2001)
Staphylococcus aureus meningitis in adults:: A clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains
WN Chang et al.
INFECTION (2001)
Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators
AL Chamis et al.
CIRCULATION (2001)
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
TR Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Necessity of a loading dose when using vancomycin in critically ill patients
JT Wang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
E Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2001)
Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
RH Drew et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci
MK Lacy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit
J Albanèse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus
CH Lu et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
